(Q74117541)

English

A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy

scientific article published on 01 May 2002

Statements

A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit